SCHEMBL7746655

SCHEMBL7746655

O=C(Nc1oc(-c2ccccc2-c2cccc(O)c2)nc1-c1ccccc1Cl)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 3/20 0.43
FLT1 P17948 1/20 0.43
FLT4 P35916 1/20 0.43
DEGS1 O15121 1/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
LMNA P02545 1/20 0.42
CCNA2 P20248 1/20 0.42
CDK2 P24941 1/20 0.42
CCNA1 P78396 1/20 0.42
NPC1 O15118 1/20 0.41
KAT6A Q92794 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
TP53 P04637 1/20 0.41
MAPT P10636 1/20 0.41
SERPINE1 P05121 2/20 0.41
AGPAT2 O15120 1/20 0.41
AKR1C4 P17516 1/20 0.40
AKR1C3 P42330 1/20 0.40
AKR1C2 P52895 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7739071 0.94 KDR (0.43) KDRFLT1FLT4DEGS1MEN1
SCHEMBL7746601 0.91 KDR (0.53) KDRFLT1FLT4MEN1KMT2A
SCHEMBL7744061 0.89 KDR (0.50) KDRFLT1FLT4LMNANPC1
SCHEMBL7985540 0.89 KDR (0.47) KDRFLT1FLT4MEN1KMT2A
SCHEMBL7744664 0.88 KDR (0.55) KDRFLT1FLT4MEN1KMT2A
SCHEMBL7746649 0.84 KDR (0.47) KDRFLT1FLT4DEGS1MEN1
SCHEMBL7744170 0.84 F2 (0.45) KDRFLT1FLT4DEGS1LMNA
SCHEMBL7744781 0.84 ADCY1 (0.47) KDRFLT1FLT4MEN1KMT2A
SCHEMBL7746570 0.83 KDR (0.49) KDRFLT1FLT4MEN1KMT2A
SCHEMBL7744087 0.83 KDR (0.46) KDRFLT1FLT4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP claimed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP claimed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO claimed
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed